The Launch of the Artificial Intelligence in Medicine Institute (AIMI)
Recently, SingHealth has partnered with Duke–NUS Medical School to establish a groundbreaking joint centre called the Artificial Intelligence in Medicine Institute (AIMI). This institute is dedicated to research, education, and commercialisation of AI in healthcare, aiming to empower healthcare professionals to develop and apply AI-driven solutions.
Focus Areas of AIMI
One of the key focus areas of AIMI is promoting bench-to-bedside AI research by providing resources, grants, and expertise in healthcare AI. The institute will also support AI governance efforts to regulate the use of AI in the health ecosystem and ensure ethical treatment of healthcare data.
In addition, AIMI will facilitate the commercialisation and licensing of AI innovation, as well as the spin-off of AI-driven startups. The institute will also foster local and global collaborations to further advance the field of health AI.
Education and Training Initiatives
AIMI is committed to providing training programmes, mentorships, and conferences to educate healthcare professionals and the public on health AI. As part of this initiative, the institute will soon launch its first online training series to provide foundational insights into the unique considerations and applications of AI in healthcare.
Liu Nan, Associate Professor at Duke–NUS Medical School and co-director of AIMI, emphasized the importance of cultivating future leaders who will drive AI advancements through strategic collaborations and education.
The Larger Trend in Healthcare AI
In line with the launch of AIMI, SingHealth has entered into a memorandum of understanding with Royal Philips to collaborate on various AI integrations. These projects include embedding AI in digital image workflows, next-generation data analytics, and AI-driven smart ICU initiatives.
Furthermore, SingHealth has partnered with the Coalition for Health AI (CHAI), a US-based non-profit organization dedicated to promoting responsible AI use in healthcare. This partnership will focus on developing AI guidelines, white papers, publications, and policy recommendations to strengthen governance around AI use in Singapore’s healthcare system.
The collaboration between SingHealth and CHAI will also involve creating educational materials and workshops to enhance AI literacy and responsible AI use among clinicians, developers, and consumers. Additionally, a global summit is expected to be hosted in Singapore to discuss AI governance, ethics, and implementation with key stakeholders from around the world.
